These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 17099245)
1. Utility of large-scale transiently transfected cells for cell-based high-throughput screens to identify transient receptor potential channel A1 (TRPA1) antagonists. Chen J; Lake MR; Sabet RS; Niforatos W; Pratt SD; Cassar SC; Xu J; Gopalakrishnan S; Pereda-Lopez A; Gopalakrishnan M; Holzman TF; Moreland RB; Walter KA; Faltynek CR; Warrior U; Scott VE J Biomol Screen; 2007 Feb; 12(1):61-9. PubMed ID: 17099245 [TBL] [Abstract][Full Text] [Related]
2. Application of large-scale transient transfection to cell-based functional assays for ion channels and GPCRs. Chen J; Gopalakrishnan S; Lake MR; Bianchi BR; Locklear J; Reilly RM Methods Enzymol; 2010; 485():293-309. PubMed ID: 21050924 [TBL] [Abstract][Full Text] [Related]
3. Application of large-scale transiently transfected cells to functional assays of ion channels: different targets and assay formats. Bianchi BR; Moreland RB; Faltynek CR; Chen J Assay Drug Dev Technol; 2007 Jun; 5(3):417-24. PubMed ID: 17638541 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in the biology and medicinal chemistry of TRPA1. Rech JC; Eckert WA; Maher MP; Banke T; Bhattacharya A; Wickenden AD Future Med Chem; 2010 May; 2(5):843-58. PubMed ID: 21426205 [TBL] [Abstract][Full Text] [Related]
6. Activation of TRPA1 by farnesyl thiosalicylic acid. Maher M; Ao H; Banke T; Nasser N; Wu NT; Breitenbucher JG; Chaplan SR; Wickenden AD Mol Pharmacol; 2008 Apr; 73(4):1225-34. PubMed ID: 18171730 [TBL] [Abstract][Full Text] [Related]
7. Differentiation dependent expression of TRPA1 and TRPM8 channels in IMR-32 human neuroblastoma cells. Louhivuori LM; Bart G; Larsson KP; Louhivuori V; Näsman J; Nordström T; Koivisto AP; Akerman KE J Cell Physiol; 2009 Oct; 221(1):67-74. PubMed ID: 19507192 [TBL] [Abstract][Full Text] [Related]
8. Oxime derivatives related to AP18: Agonists and antagonists of the TRPA1 receptor. Defalco J; Steiger D; Gustafson A; Emerling DE; Kelly MG; Duncton MA Bioorg Med Chem Lett; 2010 Jan; 20(1):276-9. PubMed ID: 19945872 [TBL] [Abstract][Full Text] [Related]
9. N-1-Alkyl-2-oxo-2-aryl amides as novel antagonists of the TRPA1 receptor. Vallin KS; Sterky KJ; Nyman E; Bernström J; From R; Linde C; Minidis AB; Nolting A; Närhi K; Santangelo EM; Sehgelmeble FW; Sohn D; Strindlund J; Weigelt D Bioorg Med Chem Lett; 2012 Sep; 22(17):5485-92. PubMed ID: 22868228 [TBL] [Abstract][Full Text] [Related]
10. Caffeine activates mouse TRPA1 channels but suppresses human TRPA1 channels. Nagatomo K; Kubo Y Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17373-8. PubMed ID: 18988737 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of the chemosensory TRPA1 cation channel by volatile toxic substances promotes cell survival of small cell lung cancer cells. Schaefer EA; Stohr S; Meister M; Aigner A; Gudermann T; Buech TR Biochem Pharmacol; 2013 Feb; 85(3):426-38. PubMed ID: 23219522 [TBL] [Abstract][Full Text] [Related]
12. Species comparison and pharmacological characterization of human, monkey, rat, and mouse TRPA1 channels. Bianchi BR; Zhang XF; Reilly RM; Kym PR; Yao BB; Chen J J Pharmacol Exp Ther; 2012 May; 341(2):360-8. PubMed ID: 22319196 [TBL] [Abstract][Full Text] [Related]
13. Rb+ efflux assay for assessment of non-selective cation channel activities. Liu K; Samuel M; Harrison RK; Paslay JW Assay Drug Dev Technol; 2010 Jun; 8(3):380-8. PubMed ID: 20085483 [TBL] [Abstract][Full Text] [Related]
14. NPPB structure-specifically activates TRPA1 channels. Liu K; Samuel M; Ho M; Harrison RK; Paslay JW Biochem Pharmacol; 2010 Jul; 80(1):113-21. PubMed ID: 20226176 [TBL] [Abstract][Full Text] [Related]
16. Enhanced activation of the transient receptor potential channel TRPA1 by ajoene, an allicin derivative. Yassaka RT; Inagaki H; Fujino T; Nakatani K; Kubo T Neurosci Res; 2010 Jan; 66(1):99-105. PubMed ID: 19808063 [TBL] [Abstract][Full Text] [Related]
17. Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel. Gijsen HJ; Berthelot D; Zaja M; Brône B; Geuens I; Mercken M J Med Chem; 2010 Oct; 53(19):7011-20. PubMed ID: 20806939 [TBL] [Abstract][Full Text] [Related]
18. TRPA1 receptor localisation in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons. Anand U; Otto WR; Facer P; Zebda N; Selmer I; Gunthorpe MJ; Chessell IP; Sinisi M; Birch R; Anand P Neurosci Lett; 2008 Jun; 438(2):221-7. PubMed ID: 18456404 [TBL] [Abstract][Full Text] [Related]
19. TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD. Stokes A; Wakano C; Koblan-Huberson M; Adra CN; Fleig A; Turner H Cell Signal; 2006 Oct; 18(10):1584-94. PubMed ID: 16500080 [TBL] [Abstract][Full Text] [Related]
20. Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists. Gijsen HJ; Berthelot D; De Cleyn MA; Geuens I; Brône B; Mercken M Bioorg Med Chem Lett; 2012 Jan; 22(2):797-800. PubMed ID: 22222037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]